NCT07481201

Brief Summary

Phenylalanine is an essential amino acid that must be obtained through food. Current adult phenylalanine recommendation is based on male-conducted studies and set the same for females. These recommendations may not be appropriate for females, as they do not take into consideration the hormonal changes over the menstrual cycle. The menstrual cycle is a rhythmic hormonal process split into two phases, with hormones regulating metabolism differently. The aim of this study is to find phenylalanine requirement for healthy, menstruating females. An innovative, non-invasive technique utilizing pre-determined diets, safe stable isotopes, and a simple breath collection method will be used. Previous work done by Elango Lab investigators has applied this method to investigate other amino acids in pregnant, non-pregnant, and lactating females as well as in children.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
30mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
May 2026Dec 2028

First Submitted

Initial submission to the registry

March 13, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 18, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

2.6 years

First QC Date

March 13, 2026

Last Update Submit

May 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Carbon 13 Oxidation

    Urine and breath samples will be collected to measure the rate of L-\[1-13C\]-leucine oxidation.

    8 hours

Study Arms (1)

Test Phenylalanine Intake

EXPERIMENTAL

Randomly assigned one of 7 test phenylalanine intakes that range from deficient to excess (2.5mg/kg/d to 22.5mg/kg/d). Participants may complete up to 7 study days in each menstrual phase, at different randomly assigned intakes.

Other: Dietary Phenylalanine Intakes

Interventions

Participants consume 8 hourly meals that contain the assigned test phenylalanine intake. Each meal will provide one-twelfth of the participants' daily energy requirements as estimated by 1.5 x Resting Energy Expenditure (REE) and adequate protein at 1.0 g.kg.d, to maintain a metabolic steady state. The meals are in the form of a crystalline amino acid protein shake, and protein-free cookies.

Test Phenylalanine Intake

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • People with menstrual cycles
  • Between the ages of 20 to 35y
  • Regular menstrual cycle (21-35 day cycle) for the past 12 months
  • Body mass index (BMI) of between 18 and 28 kg/m2
  • Free from pre-existing health conditions

You may not qualify if:

  • People who are currently using hormonal birth control or any contraceptive that would affect sex hormones
  • People on hormone therapy
  • People with an abnormal menstrual cycle history
  • People with non-traditional dietary practices
  • Recent weight loss/weight gain
  • People with a history of endocrine disorders
  • People who are pregnant
  • People who are breastfeeding
  • People who have given birth in the last 18 months
  • People who depend on medication that affects normal metabolism. Any medication that alters normal body metabolism would skew the results and compromise the validity of the data set.
  • People with a metabolic, neurological, genetic, or immune disorder likely to affect nutritional requirements or overall body metabolism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children's Hospital Research Institute

Vancouver, British Columbia, V5Z 4H4, Canada

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Single-day interventions; Repeated Measures Design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 13, 2026

First Posted

March 18, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

May 7, 2026

Record last verified: 2026-05

Locations